Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00906139Phase 4Unknown
Phase 4, randomised trial of propofol (2 arms), sponsored by Federal University of São Paulo. Primary endpoints: Efficacy (completion of procedures) at 3 months, Complications at 3 months and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00906139.